Abstract
To determine physician characteristics associated with the use of bone densitometry (BD), we conducted a cross-sectional survey of primary care practitioners in an urban community hospital. Participants were internists, geriatricians, and family practitioners. Seventy-two percent of the physicians never used BD. There was no association between physician or practice characteristics and BD use. Bone densitometry users were more likely than nonusers to treat their patients with osteoporosis or at risk of developing it. Self-reported barriers to use included cost, unfamilliarity with guidelines, uncertainty with clinical applicability, minimal impact on treatment decisions, and availability. In conclusion, although it has been shown that osteoporotic women who are aware of their BD results are more likely to accept treatment, further attention should be paid to primary care practitioners’ attitudes, knowledge, and behavior regarding the use of BD in the management of osteoporosis.
References
Peck WA. National Institute of Health Consensus Conference: Osteoporosis. JAMA. 1984;252:799–802.
Baron JA, Barrett J, Berger M. Incidence and costs to medicare of fractures among medicare beneficiaries aged>65 years—US July 1991—June 1992. MMWR. 1996;45:877–8.
Melton JL, Eddy DM, Johnston CC. Screening for osteoporosis. Ann Intern Med. 1990;112:516–28.
Johnston CC, Slemenda CW. Risk assessment: theoretical considerations. The consensus development conference on osteoporosis. Am J Med. 1993;95S5A:2–5S.
Wasnich R. Bone mass measurement: prediction of risk. The consensus development conference on osteoporosis. Am J Med. 1993;95S5A:7–10S.
WHO Study Group. Assessment of fracture risk and its application to screening for post-osteoporosis. WHO Tech Rep Theories. 1994:843.
Liberman VA, Weiss SR, Broll J, et al. Effect of oral alendronate on bone mineral density and the incidence of fracture in postmenopausal osteoporosis. N Engl J Med. 1995;333:1437–43.
Bush TL, Wells HB, James MK, et al. Effects of hormone therapy on bone mineral density: results from the PEPI trial. JAMA. 1996;276:1389–96.
Wahner H. Panel session: bone mass, bone mass measurement, technical aspects and clinical interpretation of bone mineral measurements. Public Health Rep. 1989;104S:27–30.
Tosteson ANA, Rosenthal DI, Melton J, Weinstein MC. Cost effectiveness of screening peri-menopausal women for osteoporosis; bone densitometry and hormone replacement therapy. Ann Intern Med. 1990;113:594–602.
Cummings SR, Browher WS, Grady D, Ettinger B. Should prescription of postmenopausal hormone therapy be based on the results of bone densitometry? Ann Intern Med. 1990;113:565–7.
New drugs for osteoporosis. Med Lett. 1996;38:1–3.
Riggs BL, Wahner HW. Bone densitometry in clinical decision making in osteoporosis. Ann Intern Med. 1988;108:293–5.
National Osteoporosis Foundation. Scientific Advisory Board Report. Clinical Indications for Bone Mass Measurements. Washington, DC: National Osteoporosis Foundation, submited to the Health Care Financing Administration: 1989:1–28.
Mazess RB, Barden HS. Bone densitometry for diagnosis and monitoring osteoporosis. Proc Soc Exp Biol Med. 1989;191:261–71.
Johnston CC, Slemenda CW, Melton LJ. Clinical use of bone densitometry. N Engl J Med. 1991;324:1105–9.
Genant HK, Block JE, Steiger P, et al. Appropriate use of bone densitometry. J Radiol. 1989;170:817–22.
U.S. Preventive Services Task Force. Screening for post-menopausal osteoporosis. In: Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions. Baltimore, Md: Williams & Wilkins; 1989;239–43.
Rubin SM, Cummings SR. Results of bone densitometry affects women’s decisions about taking measures to prevent fractures. Ann Intern Med. 1992;116:990–5.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Papa, L.J., Weber, B.E. Physician characteristics associated with the use of bone densitometry. J GEN INTERN MED 12, 781–783 (1997). https://doi.org/10.1046/j.1525-1497.1997.07165.x
Issue Date:
DOI: https://doi.org/10.1046/j.1525-1497.1997.07165.x